logo
Plus   Neg
Share
Email

Abbott Develops Algorithm For Diagnosing Heart Attacks - Quick Facts

Abbott (ABT) said a new research showed that Abbott's technology developed using artificial intelligence could help doctors in diagnosing heart attacks. The study involved more than 11,000 patients.

The algorithm developed by Abbott using AI tools analyze extensive data sets and identify the variables most predictive for determining a cardiac event, such as age, sex and a person's specific troponin levels and blood sample timing.

Agim Beshiri, senior medical director, global medical and scientific affairs, Diagnostics, Abbott, said: "In the future, you could imagine using this technology to develop algorithms that help doctors not only better determine if their patient is having a heart attack or not, but potentially before a heart attack occurs."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Pfizer said Friday it reached a multi-year deal with Gilead Sciences to manufacture and supply Gilead's investigational antiviral remdesivir for COVID-19 patients. Ferring Pharmaceuticals US is recalling various nasal sprays citing superpotency or amounts of desmopressin higher than specified, the U.S. Food and Drug Administration announced in a statement. The recall involves all lots on the market of DDAVP Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL, and STIMATE Nasal Spray 1.5 mg/mL. U.S. President Donald Trump has issued executive orders to ban Chinese mobile application TikTok as well as WeChat, citing a threat to national security and its economy. China's ByteDance Ltd. owns TikTok, a video-sharing mobile app, while Tencent Holdings Ltd. owns WeChat, a messaging, social media, and electronic payment app.
Follow RTT